Cooperative Agreement U01PS001570

Federal Project Grant Award Summary Partnership For Research And Action For Health received a $192,292 Project Grant from the National Institutes of Health Fogarty International Center (FIC) under the International Research and Research Training program (CFDA 93.989), effective April 1, 2026 through March 31, 2029. The grant funds an intervention adaptation and pilot randomized controlled trial addressing HIV prevention and stigma reduction among men who have sex with men (MSM) in the Georgian...

Grant Award Summary The Fogarty International Center awarded Impact Research and Development Organisation (IRDO) a $234,292 Project Grant (CFDA 93.989: International Research and Research Training) effective September 13, 2025, through August 31, 2028, to develop and pilot test a multilevel, community-based intervention addressing pre-exposure prophylaxis (PrEP) stigma among adolescent girls and young women (AGYW) ages 15–24 in western Kenya. The project deliverables include participatory...

This $1,272,341 cooperative agreement from the Centers for Disease Control and Prevention will support efforts to promote pre-exposure prophylaxis (PrEP) adherence among men who have sex with men of color. Awarded under the HIV Demonstration, Research, Public and Professional Education Projects program (CFDA 93.941), the University of North Carolina at Chapel Hill will work to develop and test improved HIV prevention strategies from September 2021 through October 2022. A subaward of $250,000...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

This Project Grant award from the National Institute of Mental Health (NIMH), authorized under the Mental Health Research Grants program (CFDA 93.242), is for $692,070 to adapt and pilot test a digital health HIV prevention intervention for Black heterosexual couples in New York State. The primary objectives are to: 1) Adapt an existing digital health intervention to meet the specific needs of this target population; and 2) Conduct a 6-month pilot randomized controlled trial with 60 couples to...

This Project Grant award in the amount of $431,712, funded by the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to improve HIV testing among children under five in rural Uganda. The primary goal is to engage with traditional healers to facilitate HIV counseling and testing via oral swab antigen tests for this vulnerable pediatric population. The award supports two key activities: 1) determining barriers and...

This federal Project Grant award of $709,872 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to develop and pilot test a couple-based intervention to address perinatal depression and improve adherence to prevention of mother-to-child transmission (PMTCT) of HIV in Malawi. The key objectives are to: 1) develop a couple-based intervention using problem-solving therapy and content on couple...

Grant Award Summary The National Institute of Mental Health (NIMH) awarded $182,912 to the Research Foundation For Mental Hygiene, Inc. (operating as the New York State Psychiatric Institute) on May 18, 2026, under the Mental Health Research Grants program (CFDA 93.242) to develop a shared decision support tool addressing HIV prevention disparities. The project, led by Dr. Laughney, will create, refine, and evaluate a web-based Pre-Exposure Prophylaxis (PrEP) Decision Aid (PDA) specifically...

This $491,655 Project Grant, awarded September 1, 2025, by the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a three-year research initiative (through June 30, 2028) at Columbia University to develop and evaluate a digital crowdsourced intervention designed to increase HIV, sexually transmitted infection (STI), and hepatitis C virus (HCV) testing uptake and overdose prevention kit utilization among sex trafficking survivors in New...

Summary The National Institute of Mental Health (NIMH) awarded Boston University Medical Campus a $179,731 Project Grant on September 1, 2025, under the Mental Health Research Grants program (CFDA 93.242) for a five-year project period extending through August 31, 2030. This Mentored Research Scientist Development Award (K01) funds the development and preliminary testing of a community health worker (CHW)-delivered pre-exposure prophylaxis (PrEP) decision aid designed to increase PrEP initiation...